ES8203845A1 - Procedimiento para preparar derivados de piridoxina - Google Patents
Procedimiento para preparar derivados de piridoxinaInfo
- Publication number
- ES8203845A1 ES8203845A1 ES502276A ES502276A ES8203845A1 ES 8203845 A1 ES8203845 A1 ES 8203845A1 ES 502276 A ES502276 A ES 502276A ES 502276 A ES502276 A ES 502276A ES 8203845 A1 ES8203845 A1 ES 8203845A1
- Authority
- ES
- Spain
- Prior art keywords
- image
- methyl
- radical
- antiadrenergic
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE PIRIDOXINA, ASI COMO DE SUS SALES DE ADICION DE ACIDO FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R R R1 PUEDEN SER VARIOS TIPOS DE RADICALES. CONSISTE EN LA REACCION DE CONDENSACION DE UNA AMINA DE FORMULA H2N-R, EN LA QUE R ES LO MISMO QUE EN LA FORMULA (I), CON 3-0-(2,3-EPOXI-PROPIL)-A,A-ISOPROPILIDENOPIRIDOXOL, EN UN DISOLVENTE ORGANICO INERTE, A LA TEMPERATURA DE REFLUJO, SEGUIDA DE LA HIDROLISIS DEL CETAL OBTENIDO EN MEDIO ACIDO FUERTE PARA OBTENER EL DERIVADO DE PIRIDOXINA, EN EL QUE R1 ES HIDROGENO, Y FINALMENTE REACCION OPCIONAL DE LA BASE LIBRE CON UN ACIDO PARA OBTENER LA BASE CORRESPONDIENTE. TAMBIEN SE PUEDE CONDENSAR LA AMINA DE FORMULA H2N - R CON UNA BROMOHIDRANA DE FORMULA (II), EN LA QUE R1 ES UN RADICAL DE FORMULA R3 - NH - C = O, SIENDO R3 UN ALQUILO C1-4.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8016516 | 1980-05-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8203845A1 true ES8203845A1 (es) | 1982-04-01 |
| ES502276A0 ES502276A0 (es) | 1982-04-01 |
Family
ID=10513518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES502276A Granted ES502276A0 (es) | 1980-05-19 | 1981-05-18 | Procedimiento para preparar derivados de piridoxina |
Country Status (32)
| Country | Link |
|---|---|
| US (1) | US4374841A (es) |
| EP (1) | EP0040591B1 (es) |
| JP (1) | JPS5711966A (es) |
| AR (1) | AR226356A1 (es) |
| AT (1) | ATE3859T1 (es) |
| AU (1) | AU542463B2 (es) |
| BG (1) | BG35327A3 (es) |
| CA (1) | CA1152080A (es) |
| CS (1) | CS223842B2 (es) |
| DD (1) | DD159071A5 (es) |
| DE (1) | DE3160480D1 (es) |
| DK (1) | DK217481A (es) |
| EG (1) | EG15890A (es) |
| ES (1) | ES502276A0 (es) |
| FI (1) | FI811525L (es) |
| GR (1) | GR82343B (es) |
| HU (1) | HU183441B (es) |
| IE (1) | IE51179B1 (es) |
| IL (1) | IL62602A (es) |
| IN (1) | IN151915B (es) |
| IS (1) | IS1183B6 (es) |
| MA (1) | MA19147A1 (es) |
| NO (1) | NO811680L (es) |
| NZ (1) | NZ196766A (es) |
| OA (1) | OA06811A (es) |
| PL (1) | PL129213B1 (es) |
| PT (1) | PT72992B (es) |
| RO (1) | RO81943A (es) |
| SU (1) | SU1077566A3 (es) |
| YU (1) | YU126281A (es) |
| ZA (1) | ZA812448B (es) |
| ZW (1) | ZW9681A1 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4663354A (en) * | 1984-04-26 | 1987-05-05 | Klinge Pharma Gmbh | Use of etilefrin and etilefrin pivalate in the long term treatment of circulatory disorders not due to hypotonia |
| DE3519693A1 (de) * | 1985-06-01 | 1987-01-02 | Basf Ag | Pyridin-derivate, ihre herstellung und verwendung |
| US6051587A (en) * | 1998-04-16 | 2000-04-18 | Medicure, Inc. | Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein |
| US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
| EP1169322B8 (en) | 1999-03-08 | 2006-09-13 | Medicure Inc. | Pyridoxal analogues for the treatment of disorders caused by a deficiency in vitamin b6 |
| AU5840200A (en) * | 1999-07-13 | 2001-01-30 | Medicure Inc. | Treatment of diabetes and related pathologies |
| AU783855B2 (en) | 1999-08-24 | 2005-12-15 | Medicure International Inc. | Compositions for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| US7442689B2 (en) * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
| WO2001064692A1 (en) | 2000-02-29 | 2001-09-07 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
| JP2003528146A (ja) | 2000-03-28 | 2003-09-24 | メディキュア インターナショナル インコーポレイテッド | 脳血管疾患の治療 |
| US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
| US6897228B2 (en) * | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
| DE60128912T9 (de) | 2000-07-07 | 2008-06-26 | Medicure International Inc. | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika |
| US20040121988A1 (en) * | 2001-03-28 | 2004-06-24 | Medicure International Inc. | Treatment of cerebrovascular disease |
| JP4048166B2 (ja) * | 2002-11-18 | 2008-02-13 | 三井製糖株式会社 | 血糖値上昇抑制剤及び体脂肪蓄積抑制剤並びに食用材料 |
| US20040186077A1 (en) * | 2003-03-17 | 2004-09-23 | Medicure International Inc. | Novel heteroaryl phosphonates as cardioprotective agents |
| EP1608379A1 (en) * | 2003-03-27 | 2005-12-28 | Medicure Inc. | Compositions for treating angina |
| EP1773370A1 (en) * | 2004-07-07 | 2007-04-18 | Medicure International Inc. | Combination therapies employing platelet aggregation drugs |
| US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
| JP2008517956A (ja) * | 2004-10-28 | 2008-05-29 | メディキュア・インターナショナル・インコーポレーテッド | 二重の抗血小板性／抗凝固性ピリドキシン類似体 |
| US7459468B2 (en) * | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
| US20060094749A1 (en) * | 2004-10-28 | 2006-05-04 | Medicure International Inc. | Substituted pyridoxines as anti-platelet agents |
| AU2006317440A1 (en) * | 2005-11-28 | 2007-05-31 | Medicure International Inc. | Selected dosage for the treatment of cardiovascular and related pathologies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR206801A1 (es) * | 1973-02-20 | 1976-08-23 | Ciba Geigy Ag | Procedimiento para la elaboracion de derivados del 1-pirid loxi-2-hidroxi-3-amino-propano |
| US4115575A (en) * | 1973-02-20 | 1978-09-19 | Ciba-Geigy Corporation | 2-(3-Amino-2-hydroxy-propoxy)-pyrazines |
| GB1485919A (en) * | 1975-08-12 | 1977-09-14 | Grindstedvaerket As | Pyridine derivatives |
| DE2711655A1 (de) * | 1977-03-17 | 1978-09-21 | Basf Ag | Pyridinyl-aminoalkylaether |
| US4210653A (en) * | 1978-06-27 | 1980-07-01 | Merck & Co., Inc. | Pyridyloxypropanolamines |
-
1981
- 1981-04-07 IL IL62602A patent/IL62602A/xx unknown
- 1981-04-08 NZ NZ196766A patent/NZ196766A/en unknown
- 1981-04-10 IS IS2631A patent/IS1183B6/is unknown
- 1981-04-13 ZA ZA00812448A patent/ZA812448B/xx unknown
- 1981-04-14 GR GR64686A patent/GR82343B/el unknown
- 1981-04-27 ZW ZW96/81A patent/ZW9681A1/xx unknown
- 1981-04-28 BG BG051875A patent/BG35327A3/xx unknown
- 1981-05-02 IN IN465/CAL/81A patent/IN151915B/en unknown
- 1981-05-07 PT PT72992A patent/PT72992B/pt unknown
- 1981-05-07 AR AR285225A patent/AR226356A1/es active
- 1981-05-11 US US06/262,449 patent/US4374841A/en not_active Expired - Fee Related
- 1981-05-12 EG EG260/81A patent/EG15890A/xx active
- 1981-05-13 AU AU70535/81A patent/AU542463B2/en not_active Ceased
- 1981-05-13 MA MA19356A patent/MA19147A1/fr unknown
- 1981-05-15 CS CS813634A patent/CS223842B2/cs unknown
- 1981-05-15 CA CA000377739A patent/CA1152080A/en not_active Expired
- 1981-05-15 AT AT81870023T patent/ATE3859T1/de not_active IP Right Cessation
- 1981-05-15 DE DE8181870023T patent/DE3160480D1/de not_active Expired
- 1981-05-15 JP JP7407681A patent/JPS5711966A/ja active Pending
- 1981-05-15 IE IE1085/81A patent/IE51179B1/en unknown
- 1981-05-15 PL PL1981231193A patent/PL129213B1/pl unknown
- 1981-05-15 YU YU01262/81A patent/YU126281A/xx unknown
- 1981-05-15 EP EP81870023A patent/EP0040591B1/fr not_active Expired
- 1981-05-18 HU HU811402A patent/HU183441B/hu unknown
- 1981-05-18 NO NO811680A patent/NO811680L/no unknown
- 1981-05-18 RO RO81104319A patent/RO81943A/ro unknown
- 1981-05-18 OA OA57404A patent/OA06811A/xx unknown
- 1981-05-18 ES ES502276A patent/ES502276A0/es active Granted
- 1981-05-18 DD DD81230039A patent/DD159071A5/de unknown
- 1981-05-18 SU SU813289800A patent/SU1077566A3/ru active
- 1981-05-18 FI FI811525A patent/FI811525L/fi not_active Application Discontinuation
- 1981-05-18 DK DK217481A patent/DK217481A/da not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8203845A1 (es) | Procedimiento para preparar derivados de piridoxina | |
| MY102087A (en) | Phenethanolamine derivatives. | |
| YU48105B (sh) | Derivati triazola i postupak za njihovo dobijanje | |
| DK160877C (da) | Fremgangsmaade til fremstilling af 2-penemforbindelser | |
| CA2036876A1 (fr) | Derives a structure naphtalenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| ES8307760A1 (es) | Un procedimiento para la preparacion de derivados de 4-anilino-pirimidina. | |
| AU6747687A (en) | New derivatives of decahydroquinoline,their preparation process, the preparation intermediates, their use as medicaments and the compositions containing them | |
| ES8507090A1 (es) | Procedimiento para la obtencion de nuevas 1, 5-benzotiacepinas | |
| ES8308543A1 (es) | "procedimiento para la preparacion de nuevas 2-fenil-2-(piridiloxi)-etilaminas sustituidas". | |
| ES465225A1 (es) | Procedimiento para la preparacion de n-cicloalcohilmetil-2- fenilamino-imidazolinas-(2). | |
| DE3363643D1 (en) | Basic substituted 4-phenyl-4,5,6,7-tetrahydrothieno(2,3-c) pyridines, process for their preparation and pharmaceutical compositions containing them | |
| ES8301219A1 (es) | Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2) sustituidas | |
| ES8503681A1 (es) | Procedimiento de preparacion de derivados del biciclo (4.2.0.) 1,3,5-octatrieno | |
| ES475596A1 (es) | Procedimiento para la preparacion de derivados de fenoxial- canolaminas | |
| SE8002545L (sv) | Arylsubstituerade furaner och sett for framstellning derav | |
| ES8504180A1 (es) | Procedimiento para preparar nuevos derivados de piperidina | |
| TW262467B (es) | ||
| NO173276C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive 1,4-disubstituerte-piperidinylderivater | |
| SE8901060D0 (sv) | New compounds | |
| ES476354A1 (es) | Procedimientos para la obtencion de nuevos derivados de ari-laminoimidazolina. | |
| SE8301785L (sv) | Sett att framstella 2-tiofen-ettiksyraderivat och mellanprodukter erforderliga for deras framstellning | |
| ES2010225A6 (es) | Procedimiento de preparacion de nuevos derivados de piperazina diona-2,6. | |
| ES488388A1 (es) | Procedimiento de preparacion de derivados hidroxilados del tiazol | |
| ES8202544A1 (es) | Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas -(2) sustituidas | |
| ES8106714A1 (es) | Procedimiento de preparar derivados 1,2,4-oxadiacinicos |